Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3763100012 | Fluocinolone acetonide 100 microgram/mL and hydroquinone 40 mg/mL and tretinoin 500 microgram/mL cutaneous cream | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 3763101011 | Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Is a | Product containing fluocinolone acetonide and hydroquinone and tretinoin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has active ingredient | Corticosterone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has active ingredient | Adrenal hormone agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has active ingredient | Hydroquinone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has active ingredient | Fluocinolone acetonide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has active ingredient | Tretinoin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Is a | Product containing tretinoin in topical dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Is a | Product containing fluocinolone in topical dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has manufactured dose form | Conventional release cutaneous cream | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Fluocinolone acetonide | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Count of base of active ingredient | 3 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has concentration strength numerator value | 100 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has basis of strength substance | Fluocinolone acetonide | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has concentration strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Is a | Product containing only fluocinolone and hydroquinone and tretinoin in cutaneous dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Tretinoin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has basis of strength substance | Tretinoin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has concentration strength numerator value | 40 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has concentration strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has concentration strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has basis of strength substance | Hydroquinone | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Hydroquinone | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Generic Tri-Luma cream | Is a | True | Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR